CClinicalTrials.gg
CompletedNCT02557178Updated Feb 24, 2021Results posted

Home-Based Health Management of COPD Patients

An interventional study of health coaching in Chronic Obstructive Pulmonary Disease, sponsored by Sara Seifert. Completed at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2021-02-24.

Sponsored by Sara Seifert · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

Minnesota HealthSolutions Corporation (MHS) proposes to develop and evaluate a program to motivate and monitor people with chronic obstructive pulmonary disease (COPD) to complete home exercise as part of pulmonary rehabilitation (PR). The proposed system has two components: home-based activity monitoring and health coaching. The investigators will conduct a randomized, wait-list controlled clinical study to evaluate the effects of the activity monitoring system and health coaching on quality of life and daily steps.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease
03

In context

Lung Diseases, Obstructive

2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.

This study's enrollment of 154 is above the median of 66 across 1,837 interventional studies indexed under Lung Diseases, Obstructive.

Browse Lung Diseases, Obstructive studies →

Lead sponsor

This is the only study on the registry with Sara Seifert as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of GOLD stage II, III, or IV COPD
  • current or previous smoker with at least 10 pack-years of cigarette smoking
  • be hospitalized for an exacerbation of COPD

Exclusion criteria

Exclusion Criteria:

  • high likelihood of being lost to follow-up or contact
  • inability to provide good data or follow commands
  • inability to do mild exercise
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
154 participants (actual)

Study arms

  • Experimental
    Activity Monitor plus Health Coaching

    Device: Actigraph Participants will wear the device daily during weeks 1, 9, and 17. Daily steps and activity will be measured. It will identify if they complete a prescribed exercise regimen. Participants in the intervention condition (wearing the Actigraph) will also receive supportive health coaching to encourage them to exercise.

    Behavioral: health coaching

  • No intervention
    Control

    Device: Actigraph Participants will wear the device daily during weeks 1, 9, and 17. Daily steps and activity will be measured. It will identify if they complete a prescribed exercise regimen.

Interventions

  • Behavioralhealth coaching

    Supportive coaching to encourage compliance with prescribed pulmonary rehabilitation.

06

What researchers measure

Primary outcomes

  1. Change in Number of Daily Steps Between the Intervention and Control Conditions

    Number of daily steps as measured by the SenseWear Pro ArmBand, which is an accepted criterion measure for daily physical activity in adults with Chronic Obstructive Pulmonary Disease.

    Time frame: Steps measured at baseline (week 1) and week 9

  2. Change in Physical Quality of Life Between the Intervention and Control Conditions

    Measure Description: The Chronic Respiratory Disease Questionnaire measures physical and emotional aspects with 20 items in four domains/categories. The two domains/categories used for physical summary were dyspnea and fatigue. The items are assessed numerically on a 7-point modified Likert scale (from 1 to 7). Scores are obtained by adding the scores for the items that make up each category and dividing by the number of items. Physical quality of life is obtained by adding the fatigue and dyspnea scores and dividing by two; hence, the score range is from 1 to 7. Higher scores indicate better health-related quality of life. Scores are obtained by adding the scores for the items that make up each category and dividing by the number of items. A minimally important difference is a change in score of 0.5 or more.

    Time frame: Quality of Life measured at baseline (week 1) and week 9

07

Results

Posted Feb 24, 2021

Participant flow

Participant flow — Overall Study
MilestoneActivity Monitor Plus Health CoachingControl
Started7274
Completed5663
Not completed1611

Outcome measures

PrimaryChange in Number of Daily Steps Between the Intervention and Control Conditions

Number of daily steps as measured by the SenseWear Pro ArmBand, which is an accepted criterion measure for daily physical activity in adults with Chronic Obstructive Pulmonary Disease.

Time frame:
Steps measured at baseline (week 1) and week 9
Reported as:
Mean · steps
Change in Number of Daily Steps Between the Intervention and Control Conditions
stepsActivity Monitor Plus Health CoachingControl
Change in Number of Daily Steps Between the Intervention and Control Conditions-344.8 ± 1657.7-975.8 ± 2596.3
PrimaryChange in Physical Quality of Life Between the Intervention and Control Conditions

Measure Description: The Chronic Respiratory Disease Questionnaire measures physical and emotional aspects with 20 items in four domains/categories. The two domains/categories used for physical summary were dyspnea and fatigue. The items are assessed numerically on a 7-point modified Likert scale (from 1 to 7). Scores are obtained by adding the scores for the items that make up each category and dividing by the number of items. Physical quality of life is obtained by adding the fatigue and dyspnea scores and dividing by two; hence, the score range is from 1 to 7. Higher scores indicate better health-related quality of life. Scores are obtained by adding the scores for the items that make up each category and dividing by the number of items. A minimally important difference is a change in score of 0.5 or more.

Time frame:
Quality of Life measured at baseline (week 1) and week 9
Reported as:
Mean · units on a scale
Change in Physical Quality of Life Between the Intervention and Control Conditions
units on a scaleActivity Monitor Plus Health CoachingControl
Change in Physical Quality of Life Between the Intervention and Control Conditions0.2 ± 1.00.0 ± 0.7

Adverse events

Collected over Adverse events were monitored through the study time frame, an average of 17 weeks per participant.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Activity Monitor Plus Health Coaching0/72 (0%)0/72 (0%)0/72 (0%)
Control0/74 (0%)0/74 (0%)0/74 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Activity Monitor Plus Health CoachingControlTotal
Mean69.4 ± 8.168.5 ± 9.168.9 ± 8.6
Sex: Female, Male
Sex: Female, Male(Participants)Activity Monitor Plus Health CoachingControlTotal
Female383775
Male343771
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Activity Monitor Plus Health CoachingControlTotal
American Indian or Alaska Native101
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American011
White7073143
More than one race000
Unknown or Not Reported101
Physical Activity from ActiGraph
Physical Activity from ActiGraph(steps)Activity Monitor Plus Health CoachingControlTotal
Mean3547.3 ± 1835.84426.3 ± 2628.34016.1 ± 2326.7
Quality of Life Physical Summary
Quality of Life Physical Summary(units on a scale)Activity Monitor Plus Health CoachingControlTotal
Mean4.3 ± 1.24.2 ± 1.14.2 ± 1.2
08

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55905, United States
09

References and documents

Publications

  • Benzo RP, Ridgeway J, Hoult JP, Novotny P, Thomas BE, Lam NM, V Benzo M, Kramer K, Seifert S. Feasibility of a Health Coaching and Home-Based Rehabilitation Intervention With Remote Monitoring for COPD. Respir Care. 2021 Jun;66(6):960-971. doi: 10.4187/respcare.08580. Epub 2021 Apr 27. PubMed 33906954 ↗

Study documents

  • Protocol and statistical analysis plan · Aug 4, 2014

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02557178
Lead sponsor
Sara Seifert
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), Mayo Clinic
Responsible party
Sara Seifert (President, Minnesota HealthSolutions) — Sponsor-investigator
First posted
Sep 23, 2015
Start date
Sep 2016
Primary completion
Mar 2019
Completion
Mar 2019
Results posted
Feb 24, 2021
Last update
Feb 24, 2021

Study contacts

Sara Seifert, MPH
principal investigator · Minnesota HealthSolutions

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion